Nanocell Biologics Inc is categorized under Biological Products Manufacturers in San Francisco, CA and active since 2009.
Nanocell Biologics Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact John Hall at the company’s single location by writing to 210 1/2 Clara St, San Francisco, California CA 94107 or by phoning (415) 706-8021. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nanocell Biologics Inc |
| Contact Person: | John Hall |
| Address: | 210 1/2 Clara St, San Francisco, California 94107 |
| Phone Number: | (415) 706-8021 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Nanocell Biologics Inc was started in 2009 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Hall for inquiries that concern Nanocell Biologics Inc by calling the company number (415) 706-8021, as your correspondence is most welcome. Additionally, the physical location of the single location of Nanocell Biologics Inc can be found at the coordinates 37.77945,-122.402629 as well as the street address 210 1/2 Clara St in San Francisco, California 94107.
For its online presence, you may visit Nanocell Biologics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.